Ascendis Pharma (ASND) free cash flow

Free cash flow · fiscal 2025
€45.41M

Ascendis Pharma (ASND) generated free cash flow of €45.41M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -€307.62M. Figures as of 18 Nov 2026, 11:49 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
€45.41M
Highest on record
€45.41Mfiscal 2025
Lowest on record
-€510.19Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Ascendis Pharma free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €45.41M in fiscal 2025 and the lowest -€510.19M in fiscal 2022.

History · 4 fiscal years

Free cash flow by fiscal year

Ascendis Pharma free cash flow, year by year

Ascendis Pharma (ASND) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025€45.41M—
2024-€307.62M—
2023-€469.80M—
2022-€510.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Ascendis Pharma and comparable companies
CompanyFree cash flowFiscal year
Revvity RVTY$509.41M2025
Exelixis EXEL$844.34M2025
Charles River Laboratories International CRL$518.49M2025
Neurocrine Biosciences NBIX$748.70M2025
Ascendis Pharma ASND€45.41M2025
ICON ICLR$861.99M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ASND

Ascendis Pharma, figure by figure

Ascendis Pharma (ASND) overview: price, valuation and scorecardAll health care companies by market value

Ascendis Pharma free cash flow: questions and answers

What is Ascendis Pharma's free cash flow?

Ascendis Pharma (ASND) generated free cash flow of €45.41M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -€307.62M.

What are the highest and lowest free cash flow figures on record for Ascendis Pharma?

Across the 4 fiscal years on record (2022–2025), the highest was €45.41M in fiscal 2025 and the lowest -€510.19M in fiscal 2022.

How is Ascendis Pharma's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Ascendis Pharma it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ascendis Pharma (ASND) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ASND/free-cash-flow

Underlying data: Yahoo Finance.